The Extension and Application of Molecular Similarity Calculations to Drug Design

Molecular complementarity plays a central role in the molecular recognition process. The quantification of this complementarity is thus of major importance in computer-aided drug design (CADD), whether one is attempting to create a pharmacophore, search a database, or derive a quantitative structure activity relationship (QSAR). Molecular similarity indices provide a convenient way in which to undertake such molecular property complementarity calculations. Here, a number of techniques are introduced through which the utility of such calculations may be improved. New “discrete” similarity indices are described, which permit more control over molecular complementarity calculations, including graphical analysis. Methods for the rapid analytical evaluation of molecular electrostatic potential (MEP) and shape are proposed, which greatly improve the similarity optimization performance. Finally, a new way to undertake three dimensional (3D) structure activity calculations using molecular similarity data is presented, which leads to the creation of extremely predictive QSAR models. The applicability of the new tools for pharmacophore elucidation and 3D QSAR generation are verified using a number of different biological test systems.

[1]  Y. Martin,et al.  3D database searching in drug design. , 1992, Journal of medicinal chemistry.

[2]  A. C. Good,et al.  The utilization of gaussian functions for the rapid evaluation of molecular similarity , 1993 .

[3]  Olga Kennard,et al.  Systematic analysis of structural data as a research technique in organic chemistry , 1983 .

[4]  Ramon Carbo,et al.  How similar is a molecule to another? An electron density measure of similarity between two molecular structures , 1980 .

[5]  P. H. Andersen,et al.  Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy. , 1990, European journal of pharmacology.

[6]  W. Graham Richards,et al.  Molecular similarity: The introduction of flexible fitting , 1990, J. Comput. Aided Mol. Des..

[7]  R. Cramer,et al.  Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.

[8]  Andrew C. Good,et al.  Utilization of Gaussian functions for the rapid evaluation of molecular similarity , 1992, J. Chem. Inf. Comput. Sci..

[9]  K F Koehler,et al.  Synthetic and computer-assisted analyses of the pharmacophore for the benzodiazepine receptor inverse agonist site. , 1990, Journal of medicinal chemistry.

[10]  Ramaswamy Nilakantan,et al.  New method for rapid characterization of molecular shapes: applications in drug design , 1993, J. Chem. Inf. Comput. Sci..

[11]  W. G. Richards,et al.  Rapid evaluation of shape similarity using Gaussian functions , 1993, J. Chem. Inf. Comput. Sci..

[12]  P. Seeman,et al.  Dopamine receptors in brain and periphery , 1987, Neurochemistry International.

[13]  T. Liljefors,et al.  A molecular mechanics approach to the understanding of presynaptic selectivity for centrally acting dopamine receptor agonists of the phenylpiperidine series. , 1986, Journal of medicinal chemistry.

[14]  P Finn,et al.  Molecular surface comparison: application to drug design. , 1993, Journal of molecular graphics.

[15]  Joseph B. Moon,et al.  3D database searching and de novo construction methods in molecular design , 1990 .

[16]  W. Graham Richards,et al.  Similarity of molecular shape , 1991, J. Comput. Aided Mol. Des..

[17]  W. Richards,et al.  Chiral drug potency: Pfeiffer's rule and computed chirality coefficients , 1993 .

[18]  N el Tayar,et al.  Toxication of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and analogs by monoamine oxidase. A structure-reactivity relationship study. , 1990, Biochemical pharmacology.

[19]  D. Manallack,et al.  A Three Dimensional Receptor Model of the Dopamine D2 Receptor from Computer Graphic Analyses of D2 Agonists , 1988, The Journal of pharmacy and pharmacology.

[20]  P. Beart,et al.  Role of assay conditions in determining agonist potency at D2 dopamine receptors in striatal homogenates. , 1986, Brain research.

[21]  Catherine Burt,et al.  The application of molecular similarity calculations , 1990 .

[22]  Gabriele Cruciani,et al.  GOLPE: An advanced chemometric tool for 3D QSAR problems , 1993 .

[23]  Ann M. Richard,et al.  Quantitative comparison of molecular electrostatic potentials for structure‐activity studies , 1991 .

[24]  D J Livingstone,et al.  Novel method for the display of multivariate data using neural networks. , 1991, Journal of molecular graphics.

[25]  Edward E. Hodgkin,et al.  A semi-empirical method for calculating molecular similarity , 1986 .

[26]  György G. Ferenczy,et al.  Semiempirical AM1 electrostatic potentials and AM1 electrostatic potential derived charges: A comparison with ab initio values , 1989 .

[27]  A. Hopfinger.  A QSAR investigation of dihydrofolate reductase inhibition by Baker triazines based upon molecular shape analysis , 1980 .

[28]  A J Hopfinger,et al.  Theory and application of molecular potential energy fields in molecular shape analysis: a quantitative structure--activity relationship study of 2,4-diamino-5-benzylpyrimidines as dihydrofolate reductase inhibitors. , 1983, Journal of medicinal chemistry.

[29]  S J Peterson,et al.  QSAR's from similarity matrices. Technique validation and application in the comparison of different similarity evaluation methods. , 1993, Journal of medicinal chemistry.

[30]  James J. P. Stewart,et al.  MOPAC: A semiempirical molecular orbital program , 1990, J. Comput. Aided Mol. Des..

[31]  B. Kowalski,et al.  Partial least-squares regression: a tutorial , 1986 .

[32]  Ferran Sanz,et al.  Automatic search for maximum similarity between molecular electrostatic potential distributions , 1991, J. Comput. Aided Mol. Des..

[33]  A. J. Hopfinger.  THEORY AND APPLICATION OF MOLECULAR POTENTIAL ENERGY FIELDS IN MOLECULAR SHAPE ANALYSIS: A QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP STUDY OF 2,4-DIAMINO-5-BENZYLPYRIMIDINES AS DIHYDROFOLATE REDUCTASE INHIBITORS , 1983 .

[34]  F I Carroll,et al.  Synthesis, ligand binding, QSAR, and CoMFA study of 3 beta-(p-substituted phenyl)tropane-2 beta-carboxylic acid methyl esters. , 1991, Journal of medicinal chemistry.

[35]  J. McFarland,et al.  Comparative molecular field analysis of anticoccidial triazines. , 1992, Journal of medicinal chemistry.

[36]  Catherine Burt,et al.  A Linear Molecular Similarity Index , 1992 .

[37]  G. Cruciani,et al.  Generating Optimal Linear PLS Estimations (GOLPE): An Advanced Chemometric Tool for Handling 3D‐QSAR Problems , 1993 .

[38]  Edward E. Hodgkin,et al.  Molecular similarity based on electrostatic potential and electric field , 1987 .

[39]  Richards Wg,et al.  QSAR's from similarity matrices. Technique validation and application in the comparison of different similarity evaluation methods. , 1993 .

[40]  S. Wold,et al.  Comparative molecular field analysis , 1991 .

[41]  A. Szabo,et al.  Modern quantum chemistry , 1982 .

[42]  A. Good,et al.  Structure-activity relationships from molecular similarity matrices. , 1993, Journal of medicinal chemistry.

[43]  V. J. V. Geerestein,et al.  3D Database searching on the basis of ligand shape using the sperm prototype method , 1990 .

[44]  P. Gill,et al.  Algorithms for the Solution of the Nonlinear Least-Squares Problem , 1978 .

[45]  P.-L. Chau,et al.  Molecular recognition: blind-searching for regions of strong structural match on the surfaces of two dissimilar molecules , 1988 .

[46]  A. Good,et al.  The calculation of molecular similarity: alternative formulas, data manipulation and graphical display. , 1992, Journal of molecular graphics.

[47]  I. Kuntz.  Structure-Based Strategies for Drug Design and Discovery , 1992, Science.